Novel coronavirus (SARS-CoV-2) infection in a patient with multivisceral transplant

Papa Gobbi, Rodrigo; Bueno, Alba; Serradilla, J; Talayero, Paloma; Stringa, Pablo Luis; Pascual Miguel, Bárbara; Alcolea Sánchez, Alida; González Sacristan, Rocío; Andres, Ane M.; López Santamaría, Manuel; Rumbo, Martín; Ramos Boluda, Esther; Hernández Oliveros, Francisco

Articulo

Registro en:

http://sedici.unlp.edu.ar/handle/10915/125785

issn:1399-3062

issn:1398-2273

https://repositorioslatinoamericanos.uchile.cl/handle/2250/7464894

Autor

Papa Gobbi, Rodrigo

Bueno, Alba

Serradilla, J

Talayero, Paloma

Stringa, Pablo Luis

Pascual Miguel, Bárbara

Alcolea Sánchez, Alida

González Sacristan, Rocío

Andres, Ane M.

López Santamaría, Manuel

Rumbo, Martín

Ramos Boluda, Esther

Hernández Oliveros, Francisco

Institución

Universidad Nacional de La Plata (Argentina)

Resumen

Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the history of modern public health, with particular emphasis in high-risk population. However, the evidence regarding their response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for COVID-19 is scant. Herein, we present the clinical and therapeutic course of a SARS-CoV-2 infection in a patient with multivisceral transplant and a recent tuberculosis infection.

Instituto de Estudios Inmunológicos y Fisiopatológicos